This issue is organized on a debate format, with experts in the field arguing the pros and cons of active controversies that challenge modern management of aortic disease. Among the controversies discussed are genetic testing, use of biomarkers, optimal methods of brain protection in aortic arch surgery, and pre-enrollment echocardiogram to exclude aortic disease for all young adults engaging in vigorous athletic or strength training.
This issue of the Thoracic Surgery Clinics will cover the following topics: cervical videomediastinoscopy, parasternal mediastinotomy, awake videothoracoscopic surgery in anterior mediastinal masses, extended transcervical thymectomy, extended transsternal thymectomy, extended videothoracoscopic thymectomy, ppen approaches to posterior mediastinal tumors in adults, videothoracoscopic approach to posterior mediastinal tumors, videothoracoscopic approach to the spine, surgical approaches for invasive tumors of the anterior mediastinum, videothoracoscopic sympathectomy, videothoracoscopic mediastinal lymphadenectomies, transcervical extended mediastinal lymphadenectomy, and robotic surgery of the mediastinum.
This issue explores the genetic basis of specific cardiomyopathies and phenotypic components of heart failure with an eye to the clinical implications of this genetic knowledge. An understanding of the genetic causes of disease can aid in development of effective prevention and management strategies.
Clinical Nuclear Cardiology—now in its fourth edition—covers the tremendous clinical growth in this field, focusing on new instrumentation and techniques. Drs. Barry L. Zaret and George A Beller address the latest developments in technology, radiopharmaceuticals, molecular imaging, and perfusion imaging. Thoroughly revised to include 20 new chapters—Digital/Fast SPECT, Imaging in Revascularized Patients, and more—this new edition provides state-of-the-art guidance on key areas and hot topics with stunning visuals. Online access to the fully searchable text at expertconsult.com includes highly illustrated case studies that let you see the problem using a variety of imaging modalities. In other words, this is an invaluable resource no clinician or researcher in nuclear cardiology should be without.
Advanced imaging technology has greatly improved the practice of thoracic surgery in the past 35 years. Among many other benefits, the advances decreased the rate of futile thoracotomy for lung cancer from more than 20% in the 1970s to the current incidence of only a few percent. This issue of Thoracic Surgery Clinics provides updates about recent advances in imaging of thoracic diseases, and will help practicing thoracic surgeons understand how to best frame requests so that optimally useful information emerges from an examination.
Epicardial ablation is a relatively new technique that is less invasive than traditional surgical ablation. It shows promise in certain patient populations. This issue of Cardiac Electrophysiology Clinics is one of the first collections of articles on this cutting edge technique.
Pharmacologic treatment of heart failure has progressed over the last two decades, but regimens have become more complex. With pharmacogenetics, the time is rapidly approaching when information on genetic variability will be used to predict therapeutic response and select the right drug for the right patient. In this issue of Heart Failure Clinics, several leading pioneers of this next revolution in heart failure treatment present the current state-of-the-art on the use of genomic information to target therapeutics. The issue begins with two articles on the basics of what every clinician needs to understand to apply genomic information to patient care and a historical overview of the move toward genetically targeted therapies. The articles that follow address specific therapeutic interventions such as neurohormonal inhibitors and beta blockers. The next series of articles address the genomics of hypertension, left ventricular hypertrophy, and how genomic differences may underlie the apparent racial differences in heart failure and therapeutics. The final third of the issue turns to how genomics will assist treatment of specific clinical scenarios, including myocarditis, transplant rejection, device therapy and pulmonary arterial hypertension. The issue concludes with a discussion of genome-wide association studies.
In the past three decades, interventional cardiology has grown tremendously due to development of new devices and expansion of indications based on clinical trials. This issue of Cardiology Clinics provides an updated view of advanced techniques in the rapidly changing and growing field of interventional cardiology. The articles included discuss important topics such as emerging techniques for vulnerable plaque detection, coronary bifurcation lesions, drug eluting stents, and left ventricular assist devices.